PLA2G7 gene polymorphisms and coronary heart disease risk: A meta-analysis

被引:23
作者
Wang, Qianqian
Hao, Yongchen
Mo, Xingbo
Wang, Laiyuan
Lu, Xiangfeng
Huang, Jianfeng
Cao, Jie
Li, Hongfan
Gu, Dongfeng [1 ]
机构
[1] Chinese Acad Med Sci, Dept Evidence Based Med, Cardiovasc Inst, Fu Wai Hosp, Beijing 100037, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
PLA2G7; Polymorphism; Coronary heart disease; Meta-analysis; ACTIVATING-FACTOR-ACETYLHYDROLASE; LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LUDWIGSHAFEN RISK; A(2); ASSOCIATION;
D O I
10.1016/j.thromres.2010.09.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Variants of PLA2G7 gene have been reported to be associated with coronary heart disease (CHD) since ten years ago, but the available data on this relationship are inconsistent. A meta-analysis was conducted to assess the effect of PLA2G7 gene on CHD. Materials and Methods: Association studies were identified from the databases of PubMed, EMbase, Chinese National Knowledge Infrastructure (CNKI) and Wanfang by two investigators and pooled effects (odds ratio (OR), together with 95% confidence interval (CI)) were calculated. Results: 14 association studies focusing on three polymorphisms (A379V, V279F and R92H) in PLA2G7 gene and risk of CHD were included in meta-analysis, covering a total of 8,280 cases and 5,656 controls. Concerning R92H, a significantly increased CHD risk was observed in recessive model, with an OR of 1.31(1.02, 1.68). Nevertheless, combined analyses of studies of the A379V and V279F variants showed no significant overall association with CHD, yielding ORs of 0.99(0.85, 1.15) and 1.09(0.88, 1.35) in allelic analysis, with strong evidence of heterogeneity. Similar results were also obtained in dominant and recessive models. Conclusions: The results indicate 92H allele had probably increased the risk of CHD, while the hypothesized effects of A379V and V279F polymorphisms on CHD cannot be confirmed in present data. However, given the limited number of studies and the potential biases, the influence of these polymorphisms on CHD risk needs further investigation. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 45 条
[21]   Assessment of cumulative evidence on genetic associations: interim guidelines [J].
Ioannidis, John P.A. ;
Boffetta, Paolo ;
Little, Julian ;
O'Brien, Thomas R. ;
Uitterlinden, Andre G. ;
Vineis, Paolo ;
Balding, David J. ;
Chokkalingam, Anand ;
Dolan, Siobhan M. ;
Flanders, W. Dana ;
Higgins, Julian P. T. ;
McCarthy, Mark I. ;
McDermott, David H. ;
Page, Grier P. ;
Rebbeck, Timothy R. ;
Seminara, Daniela ;
Khoury, Muin J. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2008, 37 (01) :120-132
[22]   Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm [J].
Ito, T ;
Yasue, H ;
Yoshimura, M ;
Nakamura, S ;
Nakayama, M ;
Shimasaki, Y ;
Harada, E ;
Mizuno, Y ;
Kawano, H ;
Ogawa, H .
HUMAN GENETICS, 2002, 110 (01) :89-94
[23]   The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men [J].
Jang, Yangsoo ;
Kim, Oh Yoen ;
Koh, Soo Jeong ;
Chae, Jey Sook ;
Ko, Young Guk ;
Kim, Ji Young ;
Cho, Hongkeun ;
Jeong, Tae-Sook ;
Lee, Woo Song ;
Ordovas, Jose M. ;
Lee, Jong Ho .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3521-3527
[24]   Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population -: Results from the 14-year follow-up of a large cohort from southern Germany [J].
Koenig, W ;
Khuseyinova, N ;
Löwel, H ;
Trischler, G ;
Meisinger, C .
CIRCULATION, 2004, 110 (14) :1903-1908
[25]   Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress [J].
Koenig, Wolfgang ;
Twardella, Dorothee ;
Brenner, Hermann ;
Rothenbacher, Dietrich .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) :1586-1593
[26]   Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence [J].
Koenig, Wolfgang ;
Khuseyinova, Natalie .
CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) :85-92
[27]   The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma [J].
Kruse, S ;
Mao, XQ ;
Heinzmann, A ;
Blattmann, S ;
Roberts, MH ;
Braun, S ;
Gao, PS ;
Forster, J ;
Kuehr, J ;
Hopkin, JM ;
Shirakawa, T ;
Deichmann, KA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (05) :1522-1530
[28]   Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction [J].
Liu, PY ;
Li, YH ;
Wu, HL ;
Chao, TH ;
Tsai, LM ;
Lin, LJ ;
Shi, GY ;
Chen, JH .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) :1023-1028
[29]   Qualitative assessment of previous evidence and an updated meta-analysis confirms lack of association between the ESR1 rs2234693 (PvuII) variant and coronary heart disease in men and women [J].
Lluis-Ganella, Carla ;
Lucas, Gavin ;
Subirana, Isaac ;
Escurriol, Veronica ;
Tomas, Marta ;
Senti, Mariano ;
Sala, Joan ;
Marrugat, Jaume ;
Elosua, Roberto .
ATHEROSCLEROSIS, 2009, 207 (02) :480-486
[30]   Vasospastic angina and microvascular angina are differentially influenced by PON1 A632G polymorphism in the Japanese [J].
Mashiba, J ;
Koike, G ;
Kamiunten, H ;
Ikeda, M ;
Sunagawa, K .
CIRCULATION JOURNAL, 2005, 69 (12) :1466-1471